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Abstract 
Insufficient sleep over long durations of the lifespan is believed to adversely affect proper development and 
healthful aging, although how this might become manifested is unknown. In the present study, rats were 
repeatedly sleep-restricted during 72 days to permit maladaptations to evolve, thereby permitting study. 
Densitometric and histomorphometric analyses were performed on harvested bone. In sleep-restricted rats, 
bone lined by osteoid was reduced 45-fold and osteoid thickness was decreased, compared with controls. This 
corresponded to a decrease in osteoblast number and activity. The percentage of bone lined by osteoclasts did 
not differ from that of controls. Plasma concentrations of an osteoclast marker (TRACP 5b) were increased in 
sleep-restricted rats, indicating increased bone resorption. The low amount of new bone formation without a 
reduction in bone resorption is diagnostic of osteopenia. Bone mineral density was decreased in femurs from 
sleep-restricted rats compared with controls, indicating osteoporosis. Red marrow in sleep-restricted rats 
contained only 37% of the fat and more than twice the number of megakaryocytes compared with that of the 
control rats. These findings in marrow suggest changed plasticity and increased hematopoiesis. Plasma 
concentrations of insulin-like growth factor-1, a known, major mediator of osteoblast differentiation and the 
proliferation of progenitor cells, was decreased by 30% in sleep-restricted rats. Taken together, these findings 
suggest that chronically inadequate sleep affects bone metabolism and bone marrow composition in ways that 
have implications for development, aging, bone healing and repair, and blood cell differentiation. 
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Introduction 
Bone remodeling is a lifelong process of bone tissue resorption by osteoclasts and new bone formation by 
osteoblasts. To remain normal, apposition of bone must balance the resorption of bone. This is critical for 
normal development and for repair following injuries, surgeries and the microdamage that occurs during normal 
activity. Inadequate sleep is widely viewed as a health threat that affects normal development and healthful 
aging, but specific effects on bone metabolism and bone marrow composition are unknown. Biochemical bone 
markers, such as osteocalcin, are known to display a diurnal pattern, suggesting increased bone apposition 
during sleeping hours. However, acutely disrupted sleep, which also disrupts the major growth hormone 
secretory period, does not alter the osteocalcin diurnal pattern.1 Wolff and Money2 reported in 1977 that 
patients with reversible somatotropin deficiency had a three-fold higher growth rate during periods when sleep 
was considered good or restful compared with when sleep was considered poor or disrupted, but sleep 
otherwise was not quantified. However, growth hormone-deficient children with short statures do not 
appreciably differ from controls in the amount or regulation of slow wave sleep.3 Epidemiological evidence 
points to co-morbidity between insufficient sleep and osteoporosis, arthritis, diabetes, obesity and lung 
disease,4 reflecting the insidious nature of pathologies related to lack of sleep, but not to specific outcomes on 
bone health. In our rodent studies, we noticed sleep deprivation resulted in a progressive increase in tissue non-
specific alkaline phosphatase (unpublished), which might indicate altered bone metabolism. Follow-up analysis 
to identify the likely source of this increased alkaline phosphatase revealed a progressive decline in serum 
osteocalcin (unpublished) which then led us to investigate bone formation processes directly. 
The longitudinal design of the present study employed recurrent sleep loss over a large proportion of early 
adulthood in the rodent. The logic behind this approach is that recurrent exposure to deficient basic needs, such 
as food, water, air, warmth and sleep, produce adaptations and maladaptations that do not become manifested 
during acute deficiencies and which may result in pathology later in life. Eight rats were exposed six times to a 
10-day period of reduced and disrupted sleep. Between each sleep restriction cycle was a two-day period of 
sleep ad libitum that was intended to be a time of sleep rebound and restoration. This 72-day period of chronic 
sleep restriction constituted 10–12% of the rat lifespan. Control conditions, in another group of 10 rats, 
consisted of the same ambulation requirements used to disrupt sleep in sleep-restricted rats, only consolidated 
to permit undisturbed bouts of sleep. We previously reported that the sleep-restricted subjects became 
hyperphagic and lost body weight without malabsorption of calories.5 We also reported that despite calorie 
deficiency indicated by weight loss, protein and lipid amounts in internal organs were largely spared, while 
adipose tissue depots appeared nearly depleted.5,6 To evaluate the effects of chronic sleep restriction on bone 
health, harvested bones were analyzed for bone mineral density (BMD), apposition and resorption. Changes in 
marrow fat content and megakaryocyte number were also observed, and therefore these variables were 
quantified in all subjects. 
Methods 
Animals and experimental conditions 
Protocols for animal care and use were approved by institutional animal care and use committees at The 
Medical College of Wisconsin and the Zablocki Veterans Administration Medical Center (2560-02 and -04). 
Eighteen Sprague-Dawley rats (Harlan, Madison, WI, USA) were 27.6 (1.0 SD) weeks old and 448 (35 SD) g in 
weight at the start of the study. Surgery was performed to implant macroelectrodes for recording 
electroencephalographic signals for the purpose of quantifying wakefulness and specific sleep stages.5 The rats 
were housed under conditions of constant ambient room light (to minimize circadian rhythm amplitude and 
phase differences between the treatment conditions) and ambient temperature of 26.9 (1.1 SD)°C, within the 
thermoneutral zone for rats.7 Rats were fed ad libitum a purified diet (modified AIN-76A; Zeigler Brothers, 
Garners, PA, USA) composed of 20% protein, 45% carbohydrate, 13% fat, 10% fiber, 3.5% minerals and 1% 
vitamins by weight, with 0.26% sodium cholate to increase atherogenic properties for planned analyses of the 
cardiovascular system. The caloric density of this diet was the same as normal laboratory chow at 3.7 kcal/g with 
12% of calories from fat. 
Procedure for producing repeated cycles of sleep restriction and ambulation control 
conditions 
The Bergmann-Rechtschaffen apparatus, illustrated elsewhere,8 consisted of a large round platform (45 cm 
diameter) that could be rotated and which was divided in half by a high Plexiglas wall. Two rats were housed in 
the apparatus on the platform, one on each side of the Plexiglas wall. The floor area on each side of the platform 
was sufficient to permit a rat to eat, groom, explore and lie down fully to sleep. Beneath each side of the 
platform was a pan of shallow water approximately 2 cm deep that encouraged the rat to stay on the platform. 
The perimeter of the platform and pans was enclosed by high Plexiglas walls, open at the top. A slow (3.3 rpm) 
and short (6 s) rotation of the housing platform induced each rat to move because the rat was displaced, 
typically from a comfortable spot at the widest radius of the platform to a narrow spot closer to the shallow 
water. The experimental schedule consisted of platform rotations once per hour during a seven-day baseline 
period and then according to a schedule validated for sleep disruption and reduction during the experimental 
period.5 The schedule was derived from electronic data capture from previous experiments that had reliably 
produced highly fragmented and reduced amounts of sleep under acute conditions.9,10 These pattern files were 
concatenated into a master disk rotation program. Disk rotations each lasted 6 s and composed a daily average 
of 26% of total time. The efficacy of the programmed rotation was verified by electroencephalographic 
recordings matched to behavior, as previously reported.5 Each rat was free to step down into, sit and walk 
around in the pans; however, they almost always remained on the platform after initial exploration; this was 
presumably due to habituation during the baseline period. Each of the 10-day periods of sleep restriction was 
followed by a two-day period of ad libitum conditions except for once-hourly, 6-s disk rotations. 
The ambulation requirements were matched in control rats (ambulation controls), except that the platform 
rotations were consolidated to permit lengthy opportunities to obtain uninterrupted sleep.5 Ambulation control 
rats otherwise were maintained under the same experimental conditions of repeated exposure to 10-day 
periods of control ambulation requirements, consisting of a 90-min period, during which the platform was 
rotated for 150 s and then was stationary for 30 s, followed by 198 min without platform rotations. Identical to 
the sleep-restriction schedule, each 10-day period was separated by two-day periods of ad libitum conditions 
during 72 days. The 10-day periods of sleep restriction were characterized by highly disrupted sleep. During any 
given 10-day period, the amount of non-rapid eye movement (NREM) sleep was reduced by 26–37%, and the 
amount of paradoxical sleep (PS; also known as REM sleep) was reduced 53–67% from baseline. The 10-day 
periods of ambulation control conditions were characterized by consolidated sleep. The amount of NREM sleep 
in ambulation controls was reduced by 13–16%, and the amount of PS was unchanged from baseline.5 The two-
day sleep ad libitum periods after sleep restriction were marked by a predominant rebound of PS to 150–167% 
of baseline, while there were no changes in NREM sleep or PS from baseline after ambulation control 
conditions.5 
Bone harvesting and processing 
After the planned duration of study, each rat was gently and deeply anesthetized and exsanguinated by cardiac 
puncture. Plasma specimens and tissues were harvested as previously described.5 Femurs typically were 
dissected below the third trochanter with intact condyles. Tibias typically were dissected above the medial 
malleolus, again with intact condyles. Bone specimens were dissected free of soft tissue and fixed in 10% neutral 
buffered formalin. A set of tibia and femurs was transferred to 70% EtOH for storage. Another set was rinsed 
free of formalin, scraped clean of fascia, imaged by X-ray, decalcified in ethylenediaminetetraacetic acid (EDTA) 
and embedded in paraffin. Tibias were studied for the length of bone, the thickness of the growth plate and 
cortical bone, the number and thicknesses of trabeculae, and the number of megakaryocytes. Femurs were 
studied for the amount of bone lined by osteoid, the number and activity of osteoblasts, the amount of bone 
lined by osteoclasts, the percentage of marrow fat and BMD. 
BMD 
BMD in g/cm2 measurements on calcified bone were obtained by dual energy X-ray absorptiometry, according 
to established methodology (DEXA; GE Lunar PIXImus, Madison, WI, USA). 
Bone length 
The lengths of tibia having intact articular surfaces were measured from standard X-ray films from the most 
anterior condyles to the most posterior malleolus. 
Bone histomorphometry 
Paraffin-embedded femurs and tibias were sectioned longitudinally in 4–6 μm thickness, and stained with the 
following: hematoxylin and eosin (H&E), Masson's trichrome, Mallory aniline blue connective tissue stain or 
tartrate-resistant acid phosphatase (TRAP). Slides were coded to keep the examiner blind to the experimental 
conditions. Histomorphometry was completed by bright field microscopy (Olympus BX51 microscope and DP71 
camera, Center Valley, PA, USA and Image Pro Plus image analysis software, Media Cybernetics, Bethesda, MD, 
USA). 
Thicknesses of the growth plate, trabeculae and cortical bone 
The thickness of the superior growth plate of the tibia was measured at 12 sites located at one-third and two-
thirds of the side-to-side width of the growth plate on each of six micrographs at ×100. Measurement started at 
the top of the proliferating zone of chondrocytes and extended to the bottom of the hypertrophic zone of 
enlarged chondrocytes along the columnar organization of the chondrocytes. To measure the number and 
thicknesses of trabeculae and cortical bone, a line was drawn on each microscope slide perpendicular to the 
cortical bone at a distance of 1 mm from the longest extension of the growth plate into the metaphysis. The 
thicknesses of bone structures were measured at the line crossings. Cortical bone thickness additionally was 
measured in the narrowest part of the mid-shaft of the tibia. 
Bone apposition 
Osteoid thickness and length of bone perimeter covered were measured in the primary center of ossification in 
the femur of sections stained with Masson's trichrome. Representative micrographs are shown in Figure 1. The 
measurement region was bordered laterally by the cortex in a 2 mm band of interest in the metaphysis, starting 
0.5 mm from the longest outcrop of chondrocytes. The thickness of the osteoid was measured at two 
equidistant points in each adjacent digital image at ×400 that together covered the entire region of interest. 
 
Figure 1 Bone formation is greatly diminished in sleep-restricted rats. Representative micrograph (×400) of 
metaphyseal femur stained with Masson's trichrome in an ambulation control (a) and a sleep-restricted (b) rat. 
Osteoid is stained blue. Osteoblasts are basophilic bone-lining cells, shown here as either plump (a), considered 
activated, or flattened (b), considered quiescent. A subset of osteoblasts is designated by arrows. The 
proportion of metaphyseal bone perimeter lined by osteoid in individual ambulation control (○) and sleep-
restricted (●) rats is shown by dot plot (c). Group averages are indicated by a horizontal bar. The group 
comparison is statistically significant at P = 0.002 
Osteoblast number and activity 
The proportion of bone bordered by osteoblasts was measured in the same region as was bone apposition. 
Individual osteoblasts were counted, and the length and height of each was measured to calculate the ellipsoid 
surface area. Osteoblast activity was considered the product of osteoblast number and ellipsoid area per 
specimen. 
Osteoclast activity 
The proportion of cortical and trabecular bone perimeter lined by osteoclasts was measured at ×400 in a 2 mm-
wide frame in the metaphysis of the distal portion of the femur, as defined above. Osteoclast identification was 
facilitated by a pale mauve tint imparted by the TRAP stain, as shown by a representative micrograph in 
Figure 2. 
 
Figure 2 Osteoclast activity is not diminished in sleep-restricted rats. Representative micrograph (a, ×200) of 
metaphyseal trabeculae stained with tartrate-resistant acid phosphatase (TRAP). Osteoclasts are the mauve-
tinted, amorphous cells with a foamy appearance typically found in resorption pits, indicated by arrows. The 
proportion of metaphyseal bone perimeter lined by osteoclasts (b) and the plasma values for TRAP form 5b 
(TRACP 5b) (c) in individual ambulation control (○) and sleep-restricted (●) rats are shown in dot plots. Group 
averages are indicated by a horizontal bar. The morphometric measurement of osteoclasts (b) was not 
statistically significant, while the biochemical measurement of TRACP 5b (c) was significant at P = 0.007 
Plasma markers of bone metabolism 
Bone-resorbing osteoclasts express a high amount of TRAP form 5b (TRACP 5b), and its amount in the circulation 
correlates with osteoclast number and activity, with little diurnal variability.11,12 TRACP 5b was measured in 
EDTA-treated plasma, processed and stored at −80°C at the time of cardiac puncture during tissue harvest 
procedures. The determinations were made by using a solid-phase immunofixed enzyme activity assay 
(Immunodiagnostic Systems Ltd, Fountain Hills, AZ, USA). The range of detection was 0.47–10 U/L and the 
coefficient of variation (CV) was <5%. Insulin-like growth factor-I (IGF-1) was measured post hoc as a marker of 
bone formation instead of osteocalcin, which is unstable and subject to divergent results due, in part, to 
multiple osteocalcin peptides and biological variability.13 Determinations of IGF-1 in stored EDTA-treated plasma 
were made by immunoenzymometric assay (Immunodiagnostic Systems Ltd). The range of detection was 222–
3881 ng/mL and the CV was <5%. 
Marrow fat and megakaryocyte number 
The proportion of marrow-containing fat was determined in the distal portion of the femur in an area of 0.56 
mm2, at a distance of not more than 1 mm from the longest outcrop of the growth plate in the metaphysis. Fat 
cells were identified by well-circumscribed, rounded vacuoles. Irregular voids and trabeculae were excluded 
from the measurement area. The size of fat cells was determined by measuring the area of each of 100 cells, 
except in two specimens in which fewer than 100 cells were present. Marrow was insufficient in one specimen 
in the intended region of measurement and therefore fat cells were measured further into the diaphysis. 
Megakaryocytes were identified morphologically by their large size, lobulated nucleus and basophilic cytoplasm. 
Megakaryocyte number was counted in H&E-stained slides at ×200 within a region starting 1 mm from the 
longest outcrop of the growth plate and extending 325 μm into the metaphysis between the lateral sides of 
compact bone of the upper extremity of the tibia. 
Data analysis 
Data were compared by means of Welch's t-tests that do not assume equal variances. The family-wise type I 
error was set at P < 0.05 for all comparisons. Holm's adjustment was applied to correct for multiple 
comparisons, in which each null hypothesis is tested for rejection according to the sequential decreasing 
strength of ordered P values. Values are presented as means ± standard deviation (SD). P values considered non-
significant after the Holm's adjustment are designated NS. 
Results 
Bone apposition, resorption and density 
Sleep restriction resulted in dramatically decreased bone formation compared with ambulation control 
conditions. The proportion of bone lined by osteoid in the primary center of ossification (within the diaphysis) 
was 21.4% (15.1% SD) in ambulation control rats and only 0.5% (0.8% SD) in sleep-restricted rats, a 45-fold 
difference (P < 0.002). The decrease in osteoid in sleep-restricted rats corresponded with few osteoblasts in the 
measured region (ambulation control: 28.3 [18.4 SD] cells; sleep restricted: 0.4 [0.8 SD] cells, P = 0.001), and 10-
fold lower osteoblast activity compared with that in ambulation controls (P = 0.002). The individual values for 
the proportion of bone lined by osteoid are provided in Figure 1 with a micrograph showing the reduced 
distribution of osteoid and diminished osteoblast activity in a sleep-restricted rat compared with that of an 
ambulation control rat. Altered bone metabolism observed in histology was further manifested as a statistically 
significant reduction in BMD in sleep-restricted rats. Values for these and other histomorphometric 
measurements are shown in Table 1. IGF-1 values reflected the indices of decreased bone formation. IGF-1 
averaged 881 (85 SD) ng/mL in ambulation controls, compared with 617 (157 SD) ng/mL in sleep-restricted rats 
(P < 0.004). 
Table 1 Bone mineral density and bone measurements in chronically sleep-restricted and ambulation control 
rats 





Osteoid thickness‡ 4.0 ± 1.6 0.6 ± 1.1 0.0001† 
Bone mineral density (g/cm2) 0.213 ± 0.009 0.189 ± 0.010 0.0004† 
Osteoid (% bone perimeter)‡ 21.4 ± 15.1 0.5 ± 0.8 0.002† 
Osteoblasts (number)‡ 28.3 ± 18.4 0.4 ± 0.8 0.001† 
Osteoblast activity (μm3)‡ 1033 ± 766 11 ± 23 0.002† 
Growth plate thickness (μm) 130 ± 9 114 ± 15 0.055 
Perimeter of metaphyseal bone (μm) 10594 ± 4248 7069 ± 3702 0.091 
Tibia length (mm) 44.5 ± 0.7 43.8 ± 0.4 0.159 
Cortical bone thickness (μm) 
   
 Near growth plate 339 ± 72 308 ± 38 0.354 
 In the diaphysis 391 ± 35 358 ± 62 0.280 
Resorption surface (osteoclasts; % of bone 
perimeter) 
6.4 ± 5.6 9.8 ± 7.8 0.317 
Values are means ± standard deviation 
*N = 6–10 rats per group after unsatisfactory specimens were excluded, except for tibia length for which N = 3–5 
†Statistical significance after Holm's correction for multiple comparisons 
‡Includes zero values 
 
Osteoclasts lined 6.4 (5.6 SD)% of cortical and trabecular bone in ambulation controls and 9.8 (7.8 SD)% in sleep-
restricted rats (NS). The individual variability in the amount of bone lined by osteoclasts is shown in Figure 2, 
along with that of plasma TRACP 5b, which was detected in six of seven sleep-restricted rats but none of the 
ambulation controls (P = 0.007). The percentage of bone lined by osteoclasts and the highly significant amount 
of TRACP 5b measured in plasma were not correlated. 
Bone marrow fat cell and megakaryocyte number 
As can be seen in Figure 3, megakaryocyte number was doubled in the marrow of sleep-restricted rats compared 
with that of ambulation controls (P = 0.004). Also shown in Figure 3, the proportion of red marrow comprised of 
fat cells was decreased by 63% in sleep-restricted rats compared with that of ambulation controls (P = 0.004). 
The average sizes of fat cell vacuoles were not significantly different between groups. 
 
Figure 3 Sleep restriction increased the numbers of megakaryocytes and decreased the volume of adipose in red 
marrow. Micrographs (×400) indicate fat cell and megakaryocyte composition in red marrow in an ambulation 
control (a) and a sleep-restricted (b) rat. Fat cells are denoted by well-circumscribed vacuoles. Megakaryocytes 
are identified by their large size, large lobulated nucleus and basophilic cytoplasm. The marrow cellularity (c) 
and the number of megakaryocytes (d) in individual ambulation control (○) and sleep-restricted (●) rats are 
shown in dot plots. Group averages are indicated by a horizontal bar. Both group comparisons were each 
statistically significant at P = 0.004 
Discussion 
Bone apposition in sleep-restricted rats was marked by greatly diminished amounts of osteoid in association 
with a dramatic decrease in osteoblast number and activity. Bone resorption appeared undiminished, indicated 
by amounts of bone lined by osteoclasts that did not differ from controls and by detection of the biochemical 
marker, TRACP 5b, in the plasma of only the sleep-restricted rats, indicating increased osteoclast activity. The 
decrease in new bone formation without a decrease in bone resorption is diagnostic of osteopenia. Moreover, 
BMD in the femurs was decreased in sleep-restricted rats, indicating osteoporosis. Other histomorphometric 
determinations of bone formation, such as growth plate or cortical bone thicknesses, were not statistically 
significantly different in sleep- restricted rats compared with controls. The statistically significant findings 
demonstrate altered cancellous bone remodeling and bone volume controlled by intramembranous ossification, 
rather than changes in endochondral ossification at the growth plate, as indicated by non-significant group 
differences in growth plate thickness and tibia length (Table 1). The overall trend of the average values was 
lower in the sleep-restricted rats, except for the amount of bone lined by osteoclasts. In the marrow, 
metaphyseal fat in sleep-restricted rats was substantially decreased. Decreased marrow fat would be expected 
to affect adaptive plasticity because of its secretion of a spectrum of hormones, cytokines and growth factors 
important in the stromal and hematopoietic microenvironment.14 The decrease in marrow fat and a doubling of 
megakaryocytes in the marrow of sleep-restricted rats indicates increased hematopoiesis. 
We previously reported that these same chronically sleep-restricted rats developed a progressive negative 
energy balance, manifested by 2–3-fold increases in food intake and a 15% loss of body weight.5 We established 
that these animals were neither dehydrated nor suffering from malabsorption of calories. On one hand, this 
deep negative energy balance may provide a parsimonious explanation for arrested bone formation. This is the 
case for the lactating rat that has zero apposition of bone and high demand for minerals,15 despite a three-fold 
increase in food consumption.16 On the other hand, many physical signs of sleep restriction do not resemble 
primary calorie deficiency, suggesting that a unidirectional effect of increased energy expenditure on bone 
cannot be assumed a priori. As a primary example, most vital organ masses in sleep-restricted rats are increased 
relative to body mass instead of markedly decreased to compensate for the negative energy balance. Protein 
and lipid content in the vital organs are largely spared.6 In contrast, food restriction resulting in a 17.5% weight 
loss, comparable to that observed in sleep-restricted rats, is associated with severe organ weight losses, such as 
60% in the liver and 55% in the small intestine.17 Not only are the effects of calorie restriction opposite to those 
of sleep restriction with regard to vital organ masses, but mild calorie restriction alone has been shown to have 
a beneficial effect on metaphyseal strength, as determined in sedentary, aging rats.18 Comparisons of the sleep-
deprived state with other examples of hypermetabolism also do not provide enough similarities to conclude that 
energy expenditure during sleep restriction has only a unidirectional effect of on bone formation. For example, 
hypermetabolism induced by thyroid hormone administration results not only in increased osteoclast surface 
areas and bone loss, but in increased osteoid and osteoblast surface areas.19 Chronic cold exposure results in 
stunting of growth, but this is manifested by shorter, thicker bones due to osteoblast proliferation in the 
periosteum and resulting in intramembranous growth.20 Therefore, energy deficiency during sleep loss might 
mirror not only the demands of cellular functions of visceral organs, but perhaps also those of the bone and the 
bone marrow, as suggested by increased hematopoiesis, discussed below. Current views on bone and energy 
metabolism stress their reciprocal interactions.21,22 
Circadian rhythm disruption, which is a well-known consequence of sleep deprivation, would be expected to 
contribute to poor bone health. Sleep disruption results in a decrease in the amplitude, and possibly the phase, 
of the circadian rhythm.23,24 To balance these influences in the present study, the ambulation control rats were 
housed under the same constant, normal ambient room illumination as were sleep-restricted rats; a condition 
well known to decrease circadian rhythm amplitude and entrainment.25 Furthermore, the schedule of platform 
rotations under the ambulation control treatment was a constant routine and would not have provided diurnal 
clues for entrainment. With these comparables in place, the present outcomes suggest that sleep restriction, 
and the physiological disruption it entails, is the principle state responsible for bone and marrow pathology, 
rather than independent effects of circadian rhythm alterations. 
Physical activity is another factor expected to contribute to bone health. While the forced ambulation 
requirements were matched for sleep-restricted and ambulation control rats, differences in physical activity 
incidental to the disk rotation schedules or to treatment-induced changes in voluntary ambulation are 
conceivable. However, it is limb disuse that is associated with decreased bone formation, whereas weight-
bearing physical activity nearly always is considered beneficial to bone formation. Even strenuous dynamic 
loading promotes bone apposition and higher BMD.26,27 Static components of mechanical loading have been 
shown to suppress appositional growth in growing rats, but not in a model of skeletal maturity,28 and perhaps 
not if there also is exposure to dynamic loading.27 Furthermore, suppression of appositional growth by static 
loading appears limited to the distal growth plate, which becomes thicker,27 instead of tending towards thinner 
as in the sleep-restricted rats. Therefore, without other changes in sensitivity of the skeleton to loading induced 
by sleep loss, the bones of sleep-restricted rats should have had the capacity to adapt to meet the mechanical 
loading requirements of these experiments. 
The diminished lipid in the marrow of sleep-restricted rats is not likely due to either the weight loss or the 
calorie deficiency, but to altered differentiation of common progenitor cells. Bone marrow adipose stores are 
regulated differently from peripheral sites.29 For example, Bathija et al.30 showed that marrow fat cell volume 
remained essentially unchanged from control values in rabbits starved for 21 days to a weight loss of 34%. Both 
marrow fat cells and osteoblasts are derived from the mesenchymal stem cells. There generally exists a 
competitive balance between osteoblast activity and fat cell volume because stromal cell differentiation is 
regulated in a reciprocal manner,29 as reviewed elsewhere.14,31,32 This relationship is manifested clinically in both 
diabetes and aging, which are marked by decreased bone formation and increased bone marrow fat.29,33 The 
reductions in both osteoblast number and marrow fat volume under conditions of sleep restriction imply 
upstream effects on stimulating factors for stromal cell differentiation. 
Marrow fat is functionally related to hematopoiesis. Red marrow fat readily gives way to hematopoietic 
expansion during an increased demand to produce more blood cells.34 All hematopoietic cells arise from the 
same multipotent hematopoietic stem cells that then become differentiated into erythrocytes, granulocytes, 
megakaryocytes and lymphocytes. While this initial survey of bone and marrow in sleep-restricted rats does not 
permit us to discern the exact profile of hematopoietic changes, two components were revealed. First, two-fold 
more megakaryocytes were counted in the marrow of sleep-restricted rats compared with those of controls; this 
implies a change to the commitment of megakaryocyte-erythroid progenitor cells. Second, the prominence of 
osteoclasts in sleep-restricted rat bones implies changes in hematopoietic factors that guide the localization and 
recruitment of osteoclast precursors to sites for bone resorption. Other indirect evidence of increased 
hematopoiesis during sleep loss includes longstanding findings of mild leukocytosis in both sleep-deprived 
humans and laboratory rats.35 This leukocytosis has been shown in rats to result in phagocyte migration into 
tissues, which is an inflammatory response, as opposed to a ‘fight or flight’ or corticosterone-mediated 
neutrophilia.10 Prior studies have also revealed a mild increase in the number of immature erythrocytes in the 
bloodstream of rats under total sleep deprivation conditions in association with anemia,36 which suggests 
increased red blood cell destruction potentially exists. Other evidence of changes to hematopoietic stem cells 
during sleep loss is limited. Rolls et al.37 have reported that a short, acute period of sleep deprivation in mice 
decreases the migration of hematopoietic stem cells from marrow to blood. Guariniello et al.38 reported that 
sleep restriction in mice decreases hematopoietic stem/progenitor cells and colony-forming units in the marrow. 
The present results provide evidence of hematopoietic expansion, which implies marked changes to 
hematopoietic stem cell differentiation, and that this is consistent with evidence of cell damage and 
inflammatory processes. 
The potential functional significance of increased megakaryocyte production during sleep loss is at least two-
fold: cell engulfment and platelet production. Megakaryocytes may engulf other hematopoietic cells and debris 
by the process of emperipolesis, which does not damage the engulfed cells which then travel to the blood 
circulation within the megakaryocyte. Megakaryocte emperipolesis of cells such as granulocytes is observed 
under conditions such as neoplasms, irradiation and blood loss, during high demand for cell delivery to the 
circulation. This prediction would be consistent with signs that sleep deprivation is a state of cell injury and 
inflammatory responses.9,10 Platelet production by megakaryocytes is a highly coordinated process that involves 
pseudopodial projections of their cytoplasm through endothelial cells and delivery of platelet precursors into 
the marrow sinusoids. In night shift workers, there are reports of increases in platelets, as well as circulating 
granulocytes.39 Scheer et al.40 have demonstrated a strong circadian component to the appearance of platelet 
activation markers in blood specimens associated with the morning hours in humans, which is a time that 
coincides with a peak in adverse cardiovascular events. Megakaryocyte numbers in the present data reflect a 
change in hematopoiesis that may reflect demands for cell delivery to the circulation and the promotion of 
thrombocytosis. 
Bone metabolism and hematopoiesis are considered largely under the control of hormonal influences. Increased 
circulating corticosterone or cortisol in rats and humans, respectively, are associated with low bone 
formation.41,42 However, plasma corticosterone was decreased in these sleep-restricted rats,6 indicating that it is 
not the candidate mediator for either low bone formation or hypercatabolism. Comparably, corticosterone has 
been found unchanged in rats acutely sleep-restricted under the Bergmann–Rechtschaffen paradigm, on which 
the present method is based.10,43–45 Either unchanged or decreased cortisol has been found in nearly every 
human study of sleep restriction, as reviewed previously.6 Minor increases in cortisol concentrations have 
sometimes been detected in humans, but only at certain times of day.46 Findings of increased corticosterone in 
association with sleep disruption in other rodent models may be methodology-based.47,48 
The present results point to IGF-1 as one strong candidate mechanism that links abnormal bone turnover and 
hematopoiesis in the sleep-restricted state. Systemic IGF-1 was significantly decreased by chronic sleep-
restriction in the present study, consistent with the close association of low IGF-1 and diminished bone mass in 
clinical conditions.49 IGF-1 is a principal mediator of skeletal growth that stimulates osteoblast differentiation 
and plays important autocrine, paracrine and/or endocrine roles in the proliferation and differentiation of 
progenitor cells.49,50 IGF-1 has both stimulatory and inhibitory effects on a large variety of parameters involved 
in bone turnover and hematopoiesis, and mediates most of the anabolic and growth-promoting actions of 
growth hormone.51 The IGF-1 concentrations in sleep-restricted rats is consistent with the emerging profile of 
chronic inflammatory disease, which is known to lead to decreased IGF-1 production.52,53 Another candidate 
hormone, leptin, is also low in these sleep-restricted rats.5 This decrease is consistent with hyperphagia and loss 
of adipose tissue, from which it is produced, but inconsistent with the increase in bone mass that occurs in 
leptin-deficient mice if they are hyperphagic.54 Other hormones of pituitary, thyroidal and gonadal origin also 
participate in bone and marrow health and their roles in abnormal bone and marrow during sleep restriction are 
yet to be evaluated. 
The laboratory rat is the most common model for evaluation of developmental and osteoporotic processes in 
humans because of comparable histomorphometric changes, biochemical markers and methodology for bone 
densitometry.55,56 Implications of sleep loss on bone turnover and marrow hematopoiesis are potentially far-
reaching. If the same phenomenon occurs in humans, chronic sleep restriction could cause osteopenic bone 
leading to increased fracture risk, decreased bone healing after surgery and decreased bone development. 
Decreased bone formation would be expected to alter healthful aging and exacerbate abnormalities in bone due 
to endocrine, nutritional, hematological and metabolic disorders. Changed functional demands on mesenchymal 
and hematopoietic stem cell lineages and cell differentiation would be expected to affect disease predisposition 
and disease resistance. For instance, alterations in regulation of the bone marrow microenvironment due to 
sleep disruption would be expected to affect the success of cell transplantation, which has been an expressed 
therapeutic concern.57 Changes to regulatory factors and progenitor cells would be expected to be influential in 
regenerative medicine and in outcomes of prevention and interventional therapies. Hematopoietic 
compensation during sleep loss may point to one of the properties that account for sleep restoration, which still 
is ill-defined. Future studies will be needed to determine the extent to which the effects of chronic lack of sleep 
on bone formation and hematopoeisis can be generalized beyond adult male rats to females, and beyond 
adulthood to development, aging and declines in reproductive hormones. The extent to which there are long-
term effects on bone and marrow health after lengthy recuperation is not yet known, but enduring effects are 
expected. This is because chronic sleep restriction results in persistent abnormalities in energy expenditure, 
nutrient intake and leptin concentrations, suggesting a potential lifetime burden of physiological effects.6 
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